売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/9 |
108,200 |
6.1% |
| 2023/9 |
111,600 |
1.2% |
| 2022/9 |
102,392 |
7.4% |
| 2021/9 |
99,407 |
6.5% |
| 2020/9 |
86,847 |
4.5% |
| 2019/9 |
63,884 |
|
| 2018/9 |
54,884 |
|
| 2017/9 |
44,952 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/9 |
-1,718 |
-1.6% |
| 2023/9 |
-60,444 |
-54.2% |
| 2022/9 |
-3,965 |
-3.9% |
| 2021/9 |
-3,654 |
-3.7% |
| 2020/9 |
-1,879 |
-2.2% |
| 2019/9 |
8,647 |
|
| 2018/9 |
9,618 |
|
| 2017/9 |
8,080 |
|
|
（単位：%）
|
2017/9
|
2018/9
|
2019/9
|
2020/9
|
2021/9
|
2022/9
|
2023/9
|
2024/9
|
|
売上高
|
44,951
|
54,884
|
63,883
|
86,846
|
99,407
|
102,391
|
111,599
|
108,199
|
|
売上成長率（％）
|
-
|
|
|
36.0
|
14.5
|
3
|
9.0
|
-3.1
|
|
売上原価
|
31,843
|
36,593
|
48,239
|
82,903
|
92,936
|
94,796
|
110,303
|
101,652
|
|
売上総利益
|
13,108
|
18,290
|
15,644
|
3,942
|
6,471
|
7,595
|
1,296
|
6,547
|
|
売上総利益率（％）
|
|
|
|
4.5
|
6.5
|
7.4
|
1.2
|
6.1
|
|
研究開発費
|
1,331
|
1,652
|
1,452
|
1,123
|
1,234
|
987
|
1,274
|
1,196
|
|
営業費用
|
5,028
|
8,672
|
6,997
|
5,822
|
10,124
|
11,560
|
61,740
|
8,265
|
|
営業利益
|
8,079
|
9,617
|
8,646
|
-1,880
|
-3,654
|
-3,965
|
-60,444
|
-1,719
|
|
営業利益率 (%)
|
|
|
|
-2.2
|
-3.7
|
-3.9
|
-54.2
|
-1.6
|
|
経常（税引前）利益
|
6,928
|
8,501
|
8,441
|
-2,266
|
-4,355
|
-7,396
|
-61,751
|
-2,772
|
|
経常（税引前）利益率（％）
|
15.4
|
15.5
|
13.2
|
-2.6
|
-4.4
|
-7.2
|
-55.3
|
-2.6
|
|
法人税等合計
|
995
|
1,398
|
248
|
-1,429
|
-553
|
-1,341
|
-460
|
12
|
|
実効税率（％）
|
|
|
|
63.0
|
12.7
|
18.1
|
0.7
|
-0.4
|
|
純利益
|
5,933
|
7,103
|
8,193
|
-826
|
-3,800
|
-6,055
|
-61,061
|
-2,782
|
|
純利益率（％）
|
|
|
|
-1.0
|
-3.8
|
-5.9
|
-54.7
|
-2.6
|
|
一株あたり利益
|
0.56
|
0.52
|
0.49
|
-0.05
|
-0.17
|
-0.21
|
-1.94
|
-0.08
|
|
希薄化後一株あたり利益
|
0.56
|
0.51
|
0.49
|
-0.05
|
-0.17
|
-0.21
|
-1.94
|
-0.08
|